DeepMed Research

UNIVERSITY OF CINCINNATI

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1819-01-01

Employees: 5.9K

Market Cap: -

Website: https://www.uc.edu/

Clinical Trials

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

Phase 4

Conditions: Bipolar I Disorder

Interventions: Drug: Lithium

First Posted Date: 2008-02-06

Last Posted Date: 2016-10-06

Lead Sponsor: University of Cincinnati

Target Recruit Count: 260

Registration Number: NCT00608075

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction

Phase 1

Conditions: Heroin Dependence
Opiate Dependence
Substance Dependence

Interventions: Behavioral: CRAFT-T
Behavioral: Treatment as usual

First Posted Date: 2008-02-06

Last Posted Date: 2012-08-14

Lead Sponsor: University of Cincinnati

Target Recruit Count: 104

Registration Number: NCT00609089

Locations: 🇺🇸
Maryhaven, Columbus, Ohio, United States

Functional and Neurochemical Brain Changes Bipolar Depression

Completed

Conditions: Depression, Bipolar

First Posted Date: 2008-02-06

Last Posted Date: 2014-12-23

Lead Sponsor: University of Cincinnati

Target Recruit Count: 120

Registration Number: NCT00608296

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Phase 1

Completed

Conditions: Methamphetamine Dependence
Methamphetamine Abuse

Interventions: Drug: OROS-MPH

First Posted Date: 2008-01-29

Last Posted Date: 2017-01-12

Lead Sponsor: University of Cincinnati

Target Recruit Count: 16

Registration Number: NCT00603434

Locations: 🇺🇸
Cincinnati Addiction Research Center, Cincinnati, Ohio, United States
🇨🇦
Ventana Clinical Research Corporation, Toronto, Ontario, Canada

A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

Phase 2

Terminated

Conditions: Colorectal Cancer

Interventions: Drug: Amifostine

First Posted Date: 2008-01-25

Last Posted Date: 2023-08-01

Lead Sponsor: University of Cincinnati

Target Recruit Count: 4

Registration Number: NCT00601198

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Nutritional Supplementation in Cognitive Aging

Not Applicable

Completed

Conditions: Cognitive Aging

Interventions: Dietary Supplement: whole fruit blueberry powder
Dietary Supplement: berry placebo powder
Dietary Supplement: blueberry juice
Dietary Supplement: Concord grape juice
Dietary Supplement: placebo juice

First Posted Date: 2008-01-23

Last Posted Date: 2016-10-10

Lead Sponsor: University of Cincinnati

Target Recruit Count: 120

Registration Number: NCT00599508

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

Phase 2

Withdrawn

Conditions: Chronic Myeloid Leukemia, Blast Crisis
Acute Myeloid Leukemia

Interventions: Drug: Imatinib Mesylate
Drug: CLAG

First Posted Date: 2008-01-15

Last Posted Date: 2008-10-31

Lead Sponsor: University of Cincinnati

Target Recruit Count: 20

Registration Number: NCT00594555

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features

Phase 2

Terminated

Conditions: Recurrent Major Depressive Disorder With Atypical Features

Interventions: Drug: betahistine dihydrochloride

First Posted Date: 2008-01-03

Last Posted Date: 2017-07-25

Lead Sponsor: University of Cincinnati

Target Recruit Count: 1

Registration Number: NCT00585585

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia
Fatty Acid Deficiency

Interventions: Dietary Supplement: Omega-3 Fatty Acids
Other: Olive oil placebo
Dietary Supplement: EPA fish oil concentrate; DHA fish oil concentrate
Drug: Placebo

First Posted Date: 2008-01-03

Last Posted Date: 2011-08-02

Lead Sponsor: University of Cincinnati

Registration Number: NCT00585390

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure

Not Applicable

Completed

Conditions: Hypertension
Pre-Hypertension

Interventions: Behavioral: DASH-4-Teens
Other: Routine Care

First Posted Date: 2008-01-03

Last Posted Date: 2022-06-14

Lead Sponsor: University of Cincinnati

Target Recruit Count: 207

Registration Number: NCT00585832

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy